A Comparison of Vaccine Efficacy Elements in Advanced Stage Clinical Trial Protocols

by Paul Oloo
9th November 2020 • comment

Evaluating the Burden-of-Disease Endpoint to Assess Vaccine Efficacy

by Edde Loeliger and Bob Small
26th October 2020 • comment

COVID-19 Efficacy Endpoints in Interventional Trials: What Constitutes an Incident Clinical Disease Case and What Triggers Diagnostic Work-Up V2.0

by Edde Loeliger & Amol Chaudhari
20th October 2020 • comment

CONSIDERATIONS FOR EVALUATION OF COVID19 VACCINES

by World Health Organization
30th September 2020 • comment

Efficacy Endpoints in COVID-19 Vaccine Trials: SARS-CoV-2 Infection

by Amol Chaudhari & Edde Loeliger
25th June 2020 • comment